financetom
Business
financetom
/
Business
/
Domestic air passenger traffic jumps 57% in July compared to June: ICRA
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Domestic air passenger traffic jumps 57% in July compared to June: ICRA
Aug 5, 2021 11:19 PM

Domestic air passenger traffic jumped 57 percent to around 49 lakh in July, reflecting a significant sequential as well as year-on-year growth amid a decline in coronavirus infections, according to a report. Recording continued recovery, traffic rose 56-57 percent to 48-49 lakh in July compared to June this year when it was about 31.1 lakh. As against June 2020, the growth is 132 percent, rating agency ICRA said in the report on Thursday.

ICRA said that airlines' capacity deployment for July was around 90 percent higher than July 2020. There were around 47,200 departures last month compared to 24,770 departures in the year-ago period. On a sequential basis, it said the number of departures in July 2021 were higher by around 49 percent as COVID infections demonstrated a downward trajectory.

Kinjal Shah, Vice President & Co-Group Head at ICRA, said that for July 2021, the average daily departures were at around 1,500, significantly higher than the average daily departures of about 800 in July last year. In June this year, it was at about 1,100. "The average number of passengers per flight during July 2021 was 104, against an average of 98 passengers per flight in June 2021.”

"Though the recovery continued in July 2021, there is continued stress on demand, driven largely by the second wave of the pandemic, limiting travel to only necessary travel, while both leisure and business travel have been curtailed due to various state-wide restrictions, despite the decline in infections," she noted.

According to ICRA, rising Aviation Turbine Fuel (ATF) prices pose a near-term challenge for the airlines.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
-- SKRR Exploration Brief: Noted Military Metals Entered Into An LOI To Buy Properties In Europe; SKRR Holds 1 Million Common Shares in Capital of Military Metals
-- SKRR Exploration Brief: Noted Military Metals Entered Into An LOI To Buy Properties In Europe; SKRR Holds 1 Million Common Shares in Capital of Military Metals
Oct 10, 2024
08:18 AM EDT, 10/08/2024 (MT Newswires) -- SKRR Exploration ( SKKRF ) , which holds 1 million common shares in the capital of Military Metals Corp. ( MILIF ) , on Tuesday ...
Gilat Satellite Networks Wins $4 Million, Three-Year Latin America Bank Comms Contract
Gilat Satellite Networks Wins $4 Million, Three-Year Latin America Bank Comms Contract
Oct 10, 2024
08:21 AM EDT, 10/08/2024 (MT Newswires) -- Gilat Satellite Networks ( GILT ) said Tuesday that it has been awarded a three-year contract valued at $4 million to provide rural Latin America communities with satellite-powered banking and payment services connectivity. Gilat said it will provide communications to connect bank branches, as well as for secure communications, ATMs, and point of...
Apollo Closes $1.6 Million Investment in SCI Capital Partners
Apollo Closes $1.6 Million Investment in SCI Capital Partners
Oct 10, 2024
08:26 AM EDT, 10/08/2024 (MT Newswires) -- Apollo Global Management ( APO ) has closed a $1.6 billion investment in SCI Capital Partners, the companies said Tuesday. The deal was described as a structured continuation vehicle transaction in partnership with funds managed by Apollo to support SCI-owned companies Morton Salt and Reddy Ice, which SCI will continue to control. Apollo...
Teva Pharmaceutical Says it Receives FDA, EMA Acceptance for Prolia Biosimilar Candidate Applications
Teva Pharmaceutical Says it Receives FDA, EMA Acceptance for Prolia Biosimilar Candidate Applications
Oct 10, 2024
08:21 AM EDT, 10/08/2024 (MT Newswires) -- Teva Pharmaceutical (TEVA) said Tuesday it has received the US Food and Drug Administration's acceptance and the European Medicines Agency's validation for its applications of TVB-009P, a biosimilar candidate to Prolia to treat osteoporosis in postmenopausal women. The company anticipates the FDA's expected decision and EMA's expected opinion in H2 next year, Teva...
Copyright 2023-2026 - www.financetom.com All Rights Reserved